Century Therapeutics, Inc. Common Stock (IPSC)
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Century Therapeutics, Inc. Common Stock (IPSC) is listed on Nasdaq, where it has traded since June 18, 2021.
- Listed On
- Nasdaq
- Listed Since
- June 18, 2021
- Employees
- 78
- Market Cap
- $302M
About Century Therapeutics, Inc. Common Stock
Century Therapeutics Inc is a biotechnology company harnessing the power of allogeneic pluripotent stem cell therapies to develop potentially curative cell therapy products for autoimmune diseases, including type 1 diabetes, or T1D, and cancer. Its beta islet, T cell and NK cell programs are allogeneic, meaning it is derived from healthy donors for use in any patient, rather than being sourced from an individual for their own specific use, as is the case with autologous T cells. The cell types it can generate from iPSCs, including iPSC-derived beta islet cells, iPSC-derived CD4+ and CD8+ alphabeta T cells, or alphabeta iT cells, and iPSC- natural killer cells, or iNK cells.
Institutional ownership
In 13F filings for the quarter ended June 30, 2026, 95 institutions reported holding IPSC, with 158.0 million shares worth $387.0 million in aggregate. The largest reported holder was Tcg Crossover Management, with 17.8 million shares worth $43.4 million. Of the 5 largest holders listed below, 1 reduced its position and 4 held their positions unchanged during the quarter.
| Institution | Shares | Value | Quarter change |
|---|---|---|---|
| Tcg Crossover Management | 17,754,430 | $43M | Unchanged |
| RA Capital Management, | 17,754,430 | $43M | Unchanged |
| Versant Venture Management | 12,166,109 | $30M | Unchanged |
| Deep Track Capital | 9,462,645 | $23M | Reduced 0.26% |
| VR Adviser | 8,695,652 | $21M | Unchanged |
Form 13F is a quarterly report that institutional investment managers with at least $100 million in qualifying securities file with the SEC. It lists long positions as of the last day of the quarter and is due within 45 days of quarter end, so these holdings describe that date rather than today.
Frequently asked questions
What is IPSC?
Century Therapeutics, Inc. Common Stock (IPSC) is listed on Nasdaq, where it has traded since June 18, 2021.
Who are the largest institutional holders of IPSC?
In 13F filings for the quarter ended June 30, 2026, the largest reported holders of IPSC were Tcg Crossover Management, RA Capital Management, and Versant Venture Management.
How many institutions own IPSC?
95 institutions reported a position in IPSC for the quarter ended June 30, 2026, worth $387.0 million in total.
Did institutions buy or sell IPSC last quarter?
Of the 5 largest reported holders, 1 reduced its position and 4 held their positions unchanged during the quarter. Every reported holder and its change is on the SentiSense ownership page for IPSC.
Every reported institutional holder, plus insider and congressional trades in IPSC, on SentiSense.